Ranbaxy Laboratories has reported results for third quarter ended December 31, 2013.
The company has reported a net loss of Rs 1420.48 crore for the quarter as compared to net loss of Rs 395.96 crore for the same quarter in the previous year. Total income of the company has decreased 25.92% at Rs 1027.6 crore for Q3FY15 as compared Rs 1387.16 crore for the corresponding quarter previous year.
On the consolidated basis, the group has reported a net loss after taxes and Minority Interest of Rs 1029.72 crore for the quarter as compared to net loss of Rs 158.94 crore for the same quarter in the previous year. Total income of the company has decreased by 10.23% at Rs 2629.52 crore for quarter under review as compared to Rs 2929.23 crore for the quarter ended December 31, 2013.
